Source: Eur Respir J 2010; 35: 467-469
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Gernez Y, Tirouvanziam R, Chanez P.. Neutrophils in chronic inflammatory airway diseases: can we target them and how?. Eur Respir J 2010; 35: 467-469

Member's Comments

No comment yet.

Related content which might interest you: Host–microbe interactions in distal airways: relevance to chronic airway diseases Source: Eur Respir Rev 2015; 24: 78-91 Year: 2015 Platelets: a potential role in chronic respiratory diseases? Source: Eur Respir Rev, 30 (161) 210062; 10.1183/16000617.0062-2021 Year: 2021 IL-36? – a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021 Inflammatory cell microlocalisation and airway dysfunction: cause and effect? Source: Eur Respir J 2007; 30: 1043-1056 Year: 2007 Eosinophils as potential mediators of autoimmunity in eosinophilic lung disease Source: Eur Respir Monogr 2022; 95: 219-237 Year: 2022 Treatment: how does inflammatory phenotype influence response to treatment in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007 Lymphoid follicles in (very) severe COPD: beneficial or harmful? Source: Eur Respir J 2009; 34: 219-230 Year: 2009 Multiple inflammatory hits and the pathogenesis of severe airway disease Source: Eur Respir J 2006; 27: 884-888 Year: 2006 Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease Source: Eur Respir J 2005; 25: 640-646 Year: 2005 Chronic infectious and inflammatory disorders - when to operate? Source: Annual Congress 2003 - Surgical decision making in marginal situations Year: 2003 Th-2 signature in chronic airway diseases: towards the extinction of asthma-COPD overlap syndrome? Source: Eur Respir J, 49 (5) 1602397; 10.1183/13993003.02397-2016 Year: 2017 Airway epithelial inflammatory responses and clinical parameters in COPD Source: Eur Respir J 2003; 22: 94-99 Year: 2003 Inflammatory cells and airway remodelling in COPD: clinical implications Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications Year: 2019 Micro-RNA-125a/b target A20 and MAVS to promote inflammatory and impair antiviral responses in chronic obstructive pulmonary disease Source: International Congress 2016 – Mechanisms of disease Year: 2016 Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 325-331 Year: 2002 Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure Source: Eur Respir Rev, 30 (162) 210077; 10.1183/16000617.0077-2021 Year: 2021 Airway diseases and inflammatory bowel diseases: is it something in the air (pollution)? Source: Eur Respir J 2015; 46: 287-288 Year: 2015 Comparison of the inflammatory response between two chronic models of allergic lung inflammation Source: Eur Respir J 2007; 30: Suppl. 51, 368s Year: 2007 Chronic diseases like asthma and COPD: do they truly exist? Source: Eur Respir J 2016; 47: 359-361 Year: 2016